ARTICLE | Company News
CML Healthcare sales and marketing update
November 5, 2012 8:00 AM UTC
CML launched the Cologic test in Canada as an aid to assess risk of colorectal cancer. The test uses a mass spectrometry method to quantify the level of gastrointestinal tract serum fatty acid-446 (GTA-446) in blood. Cologic costs C$75 ($75.05) and is performed at CML's labs. ...